SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-080408
Filing Date
2017-03-13
Accepted
2017-03-13 16:49:29
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d361335ds3.htm S-3 311857
2 EX-4.4 d361335dex44.htm EX-4.4 295108
3 EX-5.1 d361335dex51.htm EX-5.1 23906
4 EX-12.1 d361335dex121.htm EX-12.1 20161
5 EX-23.2 d361335dex232.htm EX-23.2 1857
6 EX-25.1 d361335dex251.htm EX-25.1 129659
7 GRAPHIC g361335g0309185414705.jpg GRAPHIC 3885
8 GRAPHIC g361335img52.jpg GRAPHIC 2608
9 GRAPHIC g361335new51.jpg GRAPHIC 4249
  Complete submission text file 0001193125-17-080408.txt   798720
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-216659 | Film No.: 17685742
SIC: 2834 Pharmaceutical Preparations